Early Breast Cancer Event Carousel

Metastatic breast cancer study day

Tuesday 13 January 2026

Overview

This study day explores the latest approaches to managing patients with secondary (metastatic) breast cancer. Through expert-led sessions, you’ll gain an up-to-date understanding of the full patient pathway—from diagnosis through to advanced systemic and local treatment options.

The programme covers recent therapeutic advances, evolving standards of care, and evidence-based strategies for preventing and managing treatment-related toxicities.

Key information

Delivery type 

Face-to-face (in-person teaching at a dedicated venue) 

Delivery style 

Lectures, case studies, video presentations, panel discussions 

Duration 

One day 

Experience level 

Any

09:00 Registration – Zoe Brammer 

09:25 Welcome & Introduction – Dr Ciara O’Brien 

09:30 Acute Oncology – Dr Caroline Wilson 

09:50 GP Perspective – Dr Patricia Burney 

10:10 Supportive Oncology – Sophie Maycock & Robyn Taylor 

10:30 Secondary Breast Cancer – TBC 

11:00 Break 

11:15 ER Positive – Dr Sacha Howell 

11:35 Triple Negative – Dr Anne Armstrong 

12:00 HER2 Positive – Dr Alex Lewis 

12:30 Lunch 

14:00 Updates in Secondary Breast Cancer – Session 2 

The logo for Gilead Oncology.

What to expect 

Delivered by national specialists in metastatic breast cancer, this study day offers a comprehensive, clinically focused update that blends cutting-edge evidence with practical, real-world guidance for everyday oncology practice.

Learning outcomes 

By the end of this study day, participants will be able to: 

  • Describe current best practice in managing secondary breast cancer across all major subtypes, including HER2+, triple negative, and hormone receptor–positive disease. 
  • Evaluate new and emerging systemic and loco-regional therapies. 
  • Recognise and manage common toxicities associated with treatment. 
  • Apply patient-centred approaches to support those living with metastatic breast cancer. 

Sessions will be interactive to support discussion, reflection, and practical learning. 

Who is it for? 

Oncology professionals—including allied health professionals, pharmacists, and nurses—as well as General Practitioners supporting patients with secondary breast cancer. 

How to book/learn more 

You can book this course on Eventbrite.

Not ready to book? Find out more